Bioethical Silence & Black Lives
By Derek Ayeh,
Voices in Bioethics
| 08. 03. 2015
When confirmation was released that researchers from China had genetically modified human embryos for the first time ever, there was a sudden explosion of activity on the web from the bioethics community. Physicians, academics, and anyone else who could claim some affiliation to the field wrote articles for magazines discussing the ethical dimensions of the issue. After all, human enhancement and genetic modification are staples of bioethical discourse. Who wouldn’t want to add their two cents and take part in such an important discussion?
Conversely, when the news of Freddie Gray’s death became public, I was greeted by a surprising but familiar bioethical silence. Surprising because I thought that the relationship between Freddie Gray’s death and bioethics was rather obvious: here was a man who requested healthcare numerous times but was refused it—the justification being that he was a criminal and either faking his pain or self-inflicting it. While there are likely numerous reasons why Freddie Gray died, do bystanders have moral responsibilities when they witness an injured person? There’s often debate about whether a bystander has a moral responsibility...
Related Articles
By Tomoko Otake, The Japan Times | 04.09.2024
A decade ago, researcher Haruko Obokata caused a sensation when she published two papers in the journal Nature, in which she claimed that she had discovered a way to create stem cells easily using the so-called STAP method.
With STAP...
By Yelena Biberman and Jonathan D. Moreno, Bioethics Forum | 04.16.2024
A quiet biological revolution in warfare is underway. The genome is emerging as a new domain of conflict. The level of destruction that only nuclear weapons could previously achieve is fast becoming as accessible as a cyberattack.
Now for the...
CGS is excited to announce the launch of a new anti-eugenics initiative that has been years in the making. Legacies of Eugenics in Science, Medicine, and Technology kicks off with a monthly essay series published at the Los Angeles Review of Books that will expose and contest the reemergence of eugenic ideas in contemporary health sciences, human biotechnology, public health, and medicine. Community and campus-based events featuring the authors are also being planned. The project is a collaboration among CGS...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...